| Financial Year |
March 31 2023 |
| Monetary Funds |
742,217,423.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
337,774,027.53 |
| Accounts Receivable |
625,396,806.90 |
| Advances to Suppliers |
123,033,352.84 |
| Other Receivables |
2,209,438.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
639,961,791.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,008,878.56 |
| Total Current Assets |
2,565,093,567.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
376,877,053.19 |
| Under-construction Projects |
71,408,288.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,875,703.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,688,907.89 |
| Deferred Income Tax Assets |
31,341,570.35 |
| Other Non-Current Assets |
51,961,209.04 |
| Sub-Total of Non-Current Assets |
566,419,325.78 |
| Total Assets |
3,131,512,893.05 |
| Short-Term Loans |
758,140,504.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
108,675,100.00 |
| Accounts Payable |
115,455,395.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,307,206.39 |
| Taxes Payable |
10,356,745.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,050,631.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,299,219.92 |
| Other Current Liabilities |
160,883,272.72 |
| Sub-Total of Current Liabilities |
1,243,765,629.03 |
| Long-term Loans |
46,094,443.00 |
| Bonds Payable |
474,099,063.44 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
549,520,526.83 |
| Total Liabilities |
1,793,286,155.86 |
| Paid-In Capital(Or Share Stock) |
93,319,000.00 |
| Capital Surplus |
740,630,989.52 |
| Surplus Reserve |
43,350,970.67 |
| LESS:Treasury Stock |
43,668,240.00 |
| Undistributed Profits |
465,604,589.89 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,338,226,737.19 |
| Owner's Equity（Stockholder's Equity） |
1,338,226,737.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,131,512,893.05 |
